'Luteal coasting' after GnRH agonist trigger - individualized, HCG-based, progesterone-free luteal support in 'high responders': a case series

被引:23
作者
Kol, Shahar [1 ]
Breyzman, Tatiana [1 ]
Segal, Linoy [2 ]
Humaidan, Peter [3 ,4 ]
机构
[1] IVF Unit, Dept Obstet & Gynecol, Haifa, Israel
[2] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel
[3] Aarhus Univ, Fac Hlth, Fertil Clin, Skive Reg Hosp, Aarhus, Denmark
[4] Odense Univ, Fac Hlth, Odense, Denmark
关键词
GnRHa trigger; HCG; luteal coasting; luteal support; ovarian hyperstimulation syndrome; OVARIAN HYPERSTIMULATION SYNDROME; HUMAN CHORIONIC-GONADOTROPIN; FINAL OOCYTE MATURATION; IN-VITRO FERTILIZATION; PROOF-OF-CONCEPT; HORMONE AGONIST; PHASE SUPPORT; CYCLES; IVF; PREGNANCY;
D O I
10.1016/j.rbmo.2015.09.001
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This study reports 21 IVF cases with excessive ovarian response, who received gonadotrophin-releasing hormone agonist (GnRHa) triggering for final oocyte maturation, followed by a human chorionic gonadotrophin (HCG)-based, progesterone-free, luteal support, individually timed ('luteal coasting') according to endogenous luteal progesterone concentrations. One patient developed a brief early-onset moderate ovarian hyperstimulation syndrome (OHSS) condition. Six clinical pregnancies were achieved, two of which have resulted in live births thus far. To further individualize the luteal phase support post GnRHa trigger, the same principle that holds for follicular coasting, used in the context of OHSS prevention, may be valid. Monitoring luteal progesterone concentrations from the day of oocyte retrieval, and administering a bolus of HCG (1500 IU) when the concentration drops significantly, seems to facilitate fresh embryo transfer, even in patients with excessive ovarian responses. (C) 2015 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:747 / 751
页数:5
相关论文
共 21 条
[1]   Withholding Gonadotropins Until Human Chorionic Gonadotropin Administration [J].
Abdallah, Rony ;
Kligman, Isaac ;
Davis, Owen ;
Rosenwaks, Zev .
SEMINARS IN REPRODUCTIVE MEDICINE, 2010, 28 (06) :486-492
[2]   A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization [J].
Baker, Valerie L. ;
Jones, Christopher A. ;
Doody, Kevin ;
Foulk, Russell ;
Yee, Bill ;
Adamson, G. David ;
Cometti, Barbara ;
DeVane, Gary ;
Hubert, Gary ;
Trevisan, Silvia ;
Hoehler, Fred ;
Jones, Clarence ;
Soules, Michael .
HUMAN REPRODUCTION, 2014, 29 (10) :2212-2220
[3]   Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review [J].
Delvigne, A ;
Rozenberg, S .
HUMAN REPRODUCTION UPDATE, 2002, 8 (06) :559-577
[4]   An OHSS-Free Clinic by segmentation of IVF treatment [J].
Devroey, Paul ;
Polyzos, Nikolaos P. ;
Blockeel, Christophe .
HUMAN REPRODUCTION, 2011, 26 (10) :2593-2597
[5]   Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles [J].
Fatemi, Human M. ;
Polyzos, Nikolaos P. ;
van Vaerenbergh, Inge ;
Bourgain, Claire ;
Blockeel, Christophe ;
Alsbjerg, Birgit ;
Papanikolaou, Evangelos G. ;
Humaidan, Peter .
FERTILITY AND STERILITY, 2013, 100 (03) :742-+
[6]   Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all'' approach in GnRH antagonist protocol [J].
Fatemi, Human Mousavi ;
Popovic-Todorovic, Biljana ;
Humaidan, Peter ;
Kol, Shahar ;
Banker, Manish ;
Devroey, Paul ;
Antonio Garcia-Velasco, Juan .
FERTILITY AND STERILITY, 2014, 101 (04) :1008-1011
[7]   Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders [J].
Griffin, Daniel ;
Benadiva, Claudio ;
Kummer, Nicole ;
Budinetz, Tara ;
Nulsen, John ;
Engmann, Lawrence .
FERTILITY AND STERILITY, 2012, 97 (06) :1316-1320
[8]   Gonadotrophin-releasing hormone agonist trigger and freeze-all strategy does not prevent severe ovarian hyperstimulation syndrome: a report of three cases [J].
Gurbuz, Ali Sami ;
Gode, Funda ;
Ozcimen, Necati ;
Isik, Ahmet Zeki .
REPRODUCTIVE BIOMEDICINE ONLINE, 2014, 29 (05) :541-544
[9]   HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept [J].
Haas, Jigal ;
Kedem, Alon ;
Machtinger, Ronit ;
Dar, Shir ;
Hourvitz, Ariel ;
Yerushalmi, Gil ;
Orvieto, Raoul .
JOURNAL OF OVARIAN RESEARCH, 2014, 7
[10]  
HULL MGR, 1982, FERTIL STERIL, V37, P355